| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total operating expenses | 78,359 | 76,067 | 74,728 | 57,137 |
| Loss from operations | -78,359 | -76,067 | -74,728 | -56,835 |
| Other income, net | 4,425 | 4,940 | 5,432 | 4,925 |
| Total other income | 4,425 | 4,940 | 5,432 | 4,925 |
| Net loss | -73,934 | -71,127 | -69,296 | -51,910 |
| Net loss per share attributable to common stockholders, basic (in dollars per share) | -3.36 | -3.31 | -3.29 | -2.75 |
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | -3.36 | -3.31 | -3.29 | -2.75 |
| Weighted average common shares outstanding, basic (in shares) | 21,977,268 | 21,474,827 | 21,055,834 | 18,884,562 |
| Weighted average common shares outstanding, diluted (in shares) | 21,977,268 | 21,474,827 | 21,055,834 | 18,884,562 |
Praxis Precision Medicines, Inc. (PRAX)
Praxis Precision Medicines, Inc. (PRAX)